Cedars Sinai Medical Center

Urology

Doctor Hyung L. Kim, MD practices Urology. He attended University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. He received awards:"CMS Meaningful Use Stage 1 Certification", "Essay Contest, 1st place", "Winnick research award", "1st place essay- national meeting", "best of posters (national)", "best of posters- laparoscopy", "best of posters- oncology", "Scientist Award", "Young Investigator Award", "Molecular Markers Tutorial Award", "Surgeon-Scientist Award", "Clinical Research Loan Repayment Program Award", "Edwin Beer Award", "Junior Faculty Research Award", "3rd place", "Resident Achievement Award", "Resident Award", "Scholars in Urology Award", "2nd place for basic science research", "1st place for presentation of clinical research", "1st place for basic science poster presentation", "2nd place for presentation of urologic research", "1st place for presentation of urologic research", "Pritzker Research Award", "Student Summer Research Award", "Graduation with High Honor", "Graduation with Highest Distinction", "James B. Angell Scholar", "Phi Beta Kappa", "Sigma Xi" and "Barry Goldwater Nominee". Doctor Hyung L. Kim, MD has written publications. He has 27 publications published with PubMed. The lastest paper is: 'A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance).' He is registered with Medicare.

Publications

---

• Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
• Increased Number of White Matter Lesions in Patients with Familial Cerebral Cavernous Malformations.
• Learning Curves for Robot-Assisted and Laparoscopic Partial Nephrectomy.
• Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human Cancers through the HIF-1α/OATPs signaling axis.
• The potential role for neoadjuvant therapy in Renal cell carcinoma.
• Initial experience with arterial spin-labeling MR imaging to assess histology of Renal masses.
• Evaluation of a high-throughput, microfluidics platform for performing TaqMan qPCR using formalin-fixed paraffin-embedded tumors.
• A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical Renal cell carcinoma models.
• Safety and outcomes of surgical treatment of Renal cell carcinoma in the elderly.
• Intermediate-term oncological efficacy of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ cell testicular Cancer.
• Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or Disease related factors responsible?
• Renal nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy.
• Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis facto...
• Diagnosis of early stage ovarian Cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe.
• Simplified laparoscopic partial nephrectomy using a single-layer closure and no bolsters for Renal tumors.
• Increasing age and treatment modality are predictors for subsequent diagnosis of Bladder cancer following prostate cancer diagnosis.
• Covalent crosslinking of tumor Antigens stimulates an antitumor immune response.
• Percutaneous biopsy of Renal cell carcinoma underestimates nuclear grade.
• Prospective clinical trial of preoperative sunitinib in patients with Renal cell carcinoma.
• The learning curve for robot-assisted radical cystectomy.
• A method for using life tables to estimate lifetime risk for prostate Cancer death.
• Maximizing RNA yield from archival Renal tumors and optimizing gene expression analysis.
• Impact of previous abdominal surgery on robot-assisted radical cystectomy.
• Outcomes of laparoscopic partial nephrectomy after fellowship training.
• Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded Renal cell carcinoma by RNA-seq.
• A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance).

Schools

---

• University Of ChicagoThe Pritzker School Of Medicine

• University Of Michigan

Procedures Preformed

---

• AdRenalectomy
• Cystectomy
• Cystourethroscopy and Transurethral Resection of Bladder Neck
• Kidney and Ureter Removal
• View All

Conditions Treated

---

• Bladder Atony
• Bladder Cancer
• Bladder Infection
• Bladder Stones
• View All

Doctors Specialties

---

• Urology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Essay Contest, 1st place
• Winnick research award
• 1st place essay- national meeting
• best of posters (national)
• best of posters- laparoscopy
• best of posters- oncology
• Scientist Award
• Young Investigator Award
• Molecular Markers Tutorial Award
• Surgeon-Scientist Award
• Clinical Research Loan Repayment Program Award
• Edwin Beer Award
• Junior Faculty Research Award
• 3rd place
• Resident Achievement Award
• Resident Award
• Scholars in Urology Award
• 2nd place for basic science research
• 1st place for presentation of clinical research
• 1st place for basic science poster presentation
• 2nd place for presentation of urologic research
• 1st place for presentation of urologic research
• Pritzker Research Award
• Student Summer Research Award
• Graduation with High Honor
• Graduation with Highest Distinction
• James B. Angell Scholar
• Phi Beta Kappa
• Sigma Xi
• Barry Goldwater Nominee

Education

---

• UCLA Medical Center
• University of Chicago
• University of Chicago Pritzker School of Medicine
• University of Michigan

Hospital

---

• Cedars-Sinai Medical Center

Drug Facts

---

NPI NUMBER		1609885581
NPPES Provider LastName		KIM
NPPES Provider FirstName		HYUNG
NPPES Provider ZIPCode		900485201
NPPES Provider State		CA
Specialty Description		Physical Medicine and Rehabilitation
Total Claim Count		31.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1609885581
Last Name Of The Provider	KIM
First Name Of The Provider	HYUNG
View All

Similar Doctors

---

	Dr. Arnold C. Cinman, MD This Doctor is OpenDoctor Recommended.
	Dr. John J. Summers, MD
	Dr. Hans Gritsch, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mihir Desai, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Carol J. Bennett, MD This Doctor is OpenDoctor Recommended.
	Dr. Raul J. Bendana, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeremy M. Blumberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Timothy J. Daskivich, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Brian R. Hu, MD
	Nazy Zomorodian, NP

---

Doctor Directory | TOS | twitter | FB | Angel | blog